High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine (Q34560645)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine |
scientific article |
Statements
1 reference
High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine (English)
1 reference
Barbara Pro
1 reference
Jorge E Romaguera
1 reference
Maria A Rodriguez
1 reference
Kristine R Broglio
1 reference
Frederick B Hagemeister
1 reference
Peter McLaughlin
1 reference
Anas Younes
1 reference
Felipe Samaniego
1 reference
Andre Goy
1 reference
Andreas H Sarris
1 reference
Nam H Dang
1 reference
Michael Wang
1 reference
Virginia Beasley
1 reference
L Jeffrey Medeiros
1 reference
Ruth L Katz
1 reference
Harish Gagneja
1 reference
Barry I Samuels
1 reference
Terry L Smith
1 reference
Fernando F Cabanillas
1 reference
6 September 2005
1 reference
1 reference
Identifiers
1 reference